Bio-Derived Chitosan-Based ZnO/SnO₂ Nanocomposites: Evaluation of Cytotoxic and Biomedical Potential.
Saved in:
| Title: | Bio-Derived Chitosan-Based ZnO/SnO₂ Nanocomposites: Evaluation of Cytotoxic and Biomedical Potential. |
|---|---|
| Authors: | Devi, N. Ambika1 (AUTHOR), Mohan, R.1 (AUTHOR) rp.physics16@gmail.com, Raja, T. William2,3 (AUTHOR), Sundari, M. Meenakshi1 (AUTHOR), Ayyanar, M.4 (AUTHOR), Ravikumar, P.5 (AUTHOR), Perumal, Elumalai6 (AUTHOR), Ravichandran, K.7 (AUTHOR), Pillay, Michael2 (AUTHOR) |
| Source: | Journal of Polymers & the Environment. Apr2026, Vol. 34 Issue 4, p1-18. 18p. |
| Abstract: | The present study aims to synthesize a multifunctional nanocomposite, ZnO/SnO2/CS comprising zinc oxide (ZnO), tin oxide (SnO2), and crab shell-derived biopolymer chitosan (CS), and evaluate its abilities in antioxidant, antidiabetic, anti-inflammatory, and cytotoxic applications. Cancer is a group of illnesses caused by the uncontrolled growth and proliferation of abnormal cells, is a leading cause of death worldwide, responsible for nearly one in six deaths. The treatment of cancer becomes more complicated when a patient has several comorbidities. There is a need to develop anti-cancer agents with multiple health benefits. The structural, optical, and morphological properties of the synthesized nanocomposite were carried out by XRD, FTIR, FESEM, EDS with mapping, HR-TEM, XPS, and PL spectroscopy. The biomedical potential of the nanocomposite was evaluated by antioxidants (DPPH and superoxide), antidiabetic (α-glucosidase), anti-inflammatory (protein denaturation), and cytotoxicity (MTT) assays. The nanocomposite ZnO/SnO2/CS revealed 93.86 % and 93.28 % inhibition of free radicals in the DPPH and superoxide radical scavenging assays, with IC50 values of 107.07 ± 0.41 µg/mL and 140.66 ± 1.32 µg/mL, respectively. Similarly, the nanocomposite revealed better antioxidant and anti-inflammatory capability against α-glucosidase and protein denaturation assays with IC50 values of 102.68 ± 0.82 and 131.32 ± 0.97 µg/mL, respectively. The cytotoxicity assay showed an IC50 value of 15.197 ± 1.960 µg/mL for lung cancer cells (A-549) and 18.607 ± 2.641 µg/mL for breast cancer cells (MDA-MB-231). The cell morphological analyses and EtBr fluorescence staining demonstrated the apoptosis induced cell death. The multiple health benefits of the ZnO/SnO2/CS nanocomposite make it a favourable candidate for further anticancer research. [ABSTRACT FROM AUTHOR] |
| Database: | Energy & Power Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: enr DbLabel: Energy & Power Source An: 192580397 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bio-Derived Chitosan-Based ZnO/SnO₂ Nanocomposites: Evaluation of Cytotoxic and Biomedical Potential. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Devi%2C+N%2E+Ambika%22">Devi, N. Ambika</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mohan%2C+R%2E%22">Mohan, R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> rp.physics16@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Raja%2C+T%2E+William%22">Raja, T. William</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sundari%2C+M%2E+Meenakshi%22">Sundari, M. Meenakshi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ayyanar%2C+M%2E%22">Ayyanar, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ravikumar%2C+P%2E%22">Ravikumar, P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perumal%2C+Elumalai%22">Perumal, Elumalai</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ravichandran%2C+K%2E%22">Ravichandran, K.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pillay%2C+Michael%22">Pillay, Michael</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Polymers+%26+the+Environment%22">Journal of Polymers & the Environment</searchLink>. Apr2026, Vol. 34 Issue 4, p1-18. 18p. – Name: Abstract Label: Abstract Group: Ab Data: The present study aims to synthesize a multifunctional nanocomposite, ZnO/SnO2/CS comprising zinc oxide (ZnO), tin oxide (SnO2), and crab shell-derived biopolymer chitosan (CS), and evaluate its abilities in antioxidant, antidiabetic, anti-inflammatory, and cytotoxic applications. Cancer is a group of illnesses caused by the uncontrolled growth and proliferation of abnormal cells, is a leading cause of death worldwide, responsible for nearly one in six deaths. The treatment of cancer becomes more complicated when a patient has several comorbidities. There is a need to develop anti-cancer agents with multiple health benefits. The structural, optical, and morphological properties of the synthesized nanocomposite were carried out by XRD, FTIR, FESEM, EDS with mapping, HR-TEM, XPS, and PL spectroscopy. The biomedical potential of the nanocomposite was evaluated by antioxidants (DPPH and superoxide), antidiabetic (α-glucosidase), anti-inflammatory (protein denaturation), and cytotoxicity (MTT) assays. The nanocomposite ZnO/SnO2/CS revealed 93.86 % and 93.28 % inhibition of free radicals in the DPPH and superoxide radical scavenging assays, with IC50 values of 107.07 ± 0.41 µg/mL and 140.66 ± 1.32 µg/mL, respectively. Similarly, the nanocomposite revealed better antioxidant and anti-inflammatory capability against α-glucosidase and protein denaturation assays with IC50 values of 102.68 ± 0.82 and 131.32 ± 0.97 µg/mL, respectively. The cytotoxicity assay showed an IC50 value of 15.197 ± 1.960 µg/mL for lung cancer cells (A-549) and 18.607 ± 2.641 µg/mL for breast cancer cells (MDA-MB-231). The cell morphological analyses and EtBr fluorescence staining demonstrated the apoptosis induced cell death. The multiple health benefits of the ZnO/SnO2/CS nanocomposite make it a favourable candidate for further anticancer research. [ABSTRACT FROM AUTHOR] |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=enr&AN=192580397 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10924-026-03811-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 18 StartPage: 1 Titles: – TitleFull: Bio-Derived Chitosan-Based ZnO/SnO₂ Nanocomposites: Evaluation of Cytotoxic and Biomedical Potential. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Devi, N. Ambika – PersonEntity: Name: NameFull: Mohan, R. – PersonEntity: Name: NameFull: Raja, T. William – PersonEntity: Name: NameFull: Sundari, M. Meenakshi – PersonEntity: Name: NameFull: Ayyanar, M. – PersonEntity: Name: NameFull: Ravikumar, P. – PersonEntity: Name: NameFull: Perumal, Elumalai – PersonEntity: Name: NameFull: Ravichandran, K. – PersonEntity: Name: NameFull: Pillay, Michael IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 15662543 Numbering: – Type: volume Value: 34 – Type: issue Value: 4 Titles: – TitleFull: Journal of Polymers & the Environment Type: main |
| ResultId | 1 |